TY - JOUR
T1 - Topics associated with conflict in print news coverage of the HPV vaccine during 2005 to 2009
AU - Casciotti, Dana M.
AU - Smith, Katherine C.
AU - Klassen, Ann Carroll
N1 - Funding Information:
This research was supported in part by the Richard L Gelb Cancer Prevention Faculty Innovation Award to Dr. Klassen. Dr. Casciotti was also supported by the NCI Cancer Epidemiology, Prevention and Control Institutional Training Program at Johns Hopkins Bloomberg School of Public Health (T32 CA009314), and the Johns Hopkins Carol Eliasberg Martin Scholarship in Cancer Prevention.
Publisher Copyright:
© 2015 Taylor & Francis.
PY - 2014/12/1
Y1 - 2014/12/1
N2 - HPV vaccines represent a significant advancement for cancer prevention, but vaccination against a sexually transmitted infection and possible vaccine mandates have created considerable negative publicity. We sought to understand media portrayal of vaccine-related controversy, and potential influences on attitudes and vaccine acceptance. We analyzed characteristics of media coverage of the HPV vaccine in 13 US newspapers between June 2005-May 2009, as well as relationships between conflict and pro-vaccine tone and specific story characteristics. The four-year timeframe was selected to capture coverage during the development of the vaccine, the period immediately pre- and post-approval, and the time of widespread recommendation and initial uptake. This allowed the exploration of a range of issues and provided an understanding of how coverage changed over time. Analysis included 447 news stories and opinion pieces, the majority of which were published in 2007. Most articles were positive (pro-vaccine) in tone, prompted by research/scientific advancement or legislative activities. We deemed 66% of all stories conflictcontaining. Fewer articles from 2005-2006 and 2008-2009 contained conflict than those from 2007, suggesting a peak period of concern, followed by gradual acceptance of the HPV vaccine. Legislative activities and content related to sexual activity were sources of conflict in HPV vaccine media messages. Health communication strategies can be improved by understanding and addressing potential sources of conflict in news coverage of public health initiatives.
AB - HPV vaccines represent a significant advancement for cancer prevention, but vaccination against a sexually transmitted infection and possible vaccine mandates have created considerable negative publicity. We sought to understand media portrayal of vaccine-related controversy, and potential influences on attitudes and vaccine acceptance. We analyzed characteristics of media coverage of the HPV vaccine in 13 US newspapers between June 2005-May 2009, as well as relationships between conflict and pro-vaccine tone and specific story characteristics. The four-year timeframe was selected to capture coverage during the development of the vaccine, the period immediately pre- and post-approval, and the time of widespread recommendation and initial uptake. This allowed the exploration of a range of issues and provided an understanding of how coverage changed over time. Analysis included 447 news stories and opinion pieces, the majority of which were published in 2007. Most articles were positive (pro-vaccine) in tone, prompted by research/scientific advancement or legislative activities. We deemed 66% of all stories conflictcontaining. Fewer articles from 2005-2006 and 2008-2009 contained conflict than those from 2007, suggesting a peak period of concern, followed by gradual acceptance of the HPV vaccine. Legislative activities and content related to sexual activity were sources of conflict in HPV vaccine media messages. Health communication strategies can be improved by understanding and addressing potential sources of conflict in news coverage of public health initiatives.
KW - Conflict
KW - HPV vaccine
KW - Health communication
KW - News media
UR - http://www.scopus.com/inward/record.url?scp=84922552122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922552122&partnerID=8YFLogxK
U2 - 10.4161/21645515.2014.979622
DO - 10.4161/21645515.2014.979622
M3 - Article
C2 - 25668659
AN - SCOPUS:84922552122
SN - 2164-5515
VL - 10
SP - 3466
EP - 3474
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 12
ER -